Skip to main content
. 2010 Nov 23;182(17):1864–1873. doi: 10.1503/cmaj.100771

Table 1.

Indications for measuring bone mineral density

Older adults (age ≥ 50 yr) Younger adults (age < 50 yr)
Age ≥ 65 yr (both women and men) Fragility fracture
Clinical risk factors for fracture (menopausal women, men age 50–64 yr) Prolonged use of glucocorticoids*
 Fragility fracture after age 40 yr Use of other high-risk medications
 Prolonged use of glucocorticoids* Hypogonadism or premature menopause (age < 45 yr)
 Use of other high-risk medications Malabsorption syndrome
 Parental hip fracture Primary hyperparathyroidism
 Vertebral fracture or osteopenia identified on radiography Other disorders strongly associated with rapid bone loss and/or fracture
 Current smoking
 High alcohol intake
 Low body weight (< 60 kg) or major weight loss (> 10% of body weight at age 25 yr)
 Rheumatoid arthritis
 Other disorders strongly associated with osteoporosis
*

At least three months cumulative therapy in the previous year at a prednisone-equivalent dose ≥ 7.5 mg daily.

For example, aromatase inhibitors or androgen deprivation therapy.